Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0157 | 0.1017 | 0.5 |
Onchocerca volvulus | 0.0166 | 0.1108 | 0.3431 | |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0245 | 0.1897 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0108 | 0.0523 | 0.2755 |
Trichomonas vaginalis | set domain proteins, putative | 0.0279 | 0.2235 | 0.1807 |
Trypanosoma brucei | inositol phosphorylceramide synthase | 0.1058 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0523 | 0.2755 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0138 | 0.083 | 0.1589 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0185 | 0.13 | 0.6851 |
Onchocerca volvulus | 0.0279 | 0.2235 | 1 | |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Echinococcus granulosus | geminin | 0.0579 | 0.5225 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0138 | 0.083 | 0.1589 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0185 | 0.13 | 0.2487 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0108 | 0.0523 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0174 | 0.1188 | 0.6263 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Schistosoma mansoni | alpha-glucosidase | 0.016 | 0.1042 | 0.1994 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0138 | 0.083 | 0.1589 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0108 | 0.0523 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.1108 | 0.5842 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0108 | 0.0523 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0174 | 0.1188 | 0.6263 |
Schistosoma mansoni | alpha-glucosidase | 0.016 | 0.1042 | 0.1994 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0157 | 0.1017 | 1 |
Brugia malayi | hypothetical protein | 0.0166 | 0.1108 | 0.5842 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0119 | 0.0638 | 0.3364 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0108 | 0.0523 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0523 | 0.2755 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0108 | 0.0523 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.0638 | 0.3364 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Brugia malayi | Pre-SET motif family protein | 0.0245 | 0.1897 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0108 | 0.0523 | 0.2755 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.1058 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0579 | 0.5225 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0108 | 0.0523 | 0.2755 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.0108 | 0.0523 | 0.2755 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0174 | 0.1188 | 0.6263 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0523 | 0.2755 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0138 | 0.083 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 3 | 0.0108 | 0.0523 | 0.2755 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0157 | 0.1017 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0185 | 0.13 | 0.6851 |
Echinococcus multilocularis | geminin | 0.0579 | 0.5225 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0523 | 0.2755 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0138 | 0.083 | 0.1589 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0523 | 0.2755 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0108 | 0.0523 | 0.1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0108 | 0.0523 | 0.5 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.0108 | 0.0523 | 0.1 |
Schistosoma mansoni | hypothetical protein | 0.0119 | 0.0638 | 0.1221 |
Schistosoma mansoni | hypothetical protein | 0.0579 | 0.5225 | 1 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0322 | 0.2657 | 0.5 |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.0108 | 0.0523 | 0.1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 0.2252 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0138 | 0.083 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0185 | 0.13 | 0.2487 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0322 | 0.2657 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0523 | 0.2755 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0108 | 0.0523 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0174 | 0.1188 | 0.6263 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0108 | 0.0523 | 0.2755 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0185 | 0.13 | 0.2487 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0322 | 0.2657 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 65 % | Cytotoxicity against human SH-SY5Y cells assessed as cell viability at 1 uM after 48 hrs by MTT assay | ChEMBL. | 21696175 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.